Clinical Study

Ucci-Gi-18-01- Echo Decorrelation Imaging During Standard Clinical Radiofrequency Ablation And Microwave Ablation Of Liver Cancer

Posted Date: Feb 5, 2020

  • Investigator: Truman Douglas Mast
  • Specialties: Cancer, Oncology
  • Type of Study: Observational/Survey

Echo decorrelation imaging will be performed during standard clinical radiofrequency ablation (RFA) and microwave ablation (MWA) of liver cancer.The primary objective of this study is the assessment of 3D echo decorrelation imaging as a predictor of complete long-term treatment or tumor recurrence within 15 months after ablation

Criteria:

Patients Must Have Been Treated For Primary Or Metastatic Liver Tumors At Uc Health, Thermal Ablation Already Scheduled As Soc,

Keywords:

Liver Cancer, Gastrointestinal

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.